Heart Failure 2015 - 2nd World Congress on Acute Heart Failure 2015

23 - 26 May 2015, Seville - Spain

Session Details

Late Breaking Trials I: Therapies for acute and advanced heart failure
Sat 23 May 10:30 - 12:00 Miscellaneous Special Session, World Congress on Acute Heart Failure, Acute heart failure Florence
Chairpersons: Alexandre MEBAZAA (Paris, France), Gerasimos FILIPPATOS (Athens, Greece)
Learning Objectives: This session will feature the latest breakthrough in clinical heart failure research. Trial presentations of 10 minutes followed by as discussant review and questions from the audience and chairpersons for 5 minutes.

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
10:3042Effect of treatment with intravenous nitroglycerine on short term prognosis of patients diagnosed with acute heart failure: the NITRO-EAHFE Study.Oscar MIRO (Barcelona, Spain)
10:402042Discussion: NITRO-EAHFE. 
10:4543Percutaneous annuloplasty for mitral valve repair multicentre trial resultKarl-Heinz KUCK (Hamburg, Germany)
10:552043Discussion: Percutaneous annuloplasty for mitral valve repair multicentre trial result. 
11:0044Results of the TITRATION study: a 12-week, multicenter, randomized, double-blind, safety evaluation of a 3- versus 6-week up-titration regimen of LCZ696 in patients with HFrEF Michele SENNI (Bergamo, Italy)
11:102044Discussion: TITRATION.Giuseppe M C ROSANO (London, United Kingdom)
11:1545Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency - a prospective propensity score-matched cohort studyLars LUND (Stockholm, Sweden)
11:252045Discussion: Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency - a prospective propensity score-matched cohort study.Ali AHMED (Washington, United States of America)
11:3046Clinical presentation, management, and one-year outcomes of patients admitted with acute heart failure in India.Sivadasanpillai HARIKRISHNAN (Trivandrum, India)
11:402046Discussion: Clinical presentation, management, and one-year outcomes of patients admitted with acute heart failure in India. 
11:4547Effect of sodium zirconium cyclosilicate (ZS-9) on normalization and maintenance of serum K+ in heart failure patients from the Phase 3 randomized, double-blind, placebo-controlled HARMONIZE studyStefan ANKER (Gottingen, Germany)
11:502047Discussion: HARMONIZE.Bertram PITT (Ann Arbor, United States of America)